Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease
Open Access
- 22 July 2009
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (29), 9321-9329
- https://doi.org/10.1523/jneurosci.4736-08.2009
Abstract
Downregulation of brain-derived neurotrophic factor (BDNF) in the cortex occurs early in the progression of Alzheimer's disease (AD). Since BDNF plays a critical role in neuronal survival, synaptic plasticity, and memory, BDNF reduction may contribute to synaptic and cellular loss and memory deficits characteristic of AD.In vitroevidence suggests that amyloid-β (Aβ) contributes to BDNF downregulation in AD, but the specific Aβ aggregation state responsible for this downregulationin vivois unknown. In the present study, we examined cortical levels of BDNF mRNA in three different transgenic AD mouse models harboring mutations inAPPresulting in Aβ overproduction, and in a genetic mouse model of Down syndrome. Two of the three Aβ transgenic strains (APPNLhand TgCRND8) exhibited significantly decreased cortical BDNF mRNA levels compared with wild-type mice, whereas neither the other strain (APPswe/PS-1) nor the Down syndrome mouse model (Ts65Dn) was affected. OnlyAPPNLhand TgCRND8 mice expressed high Aβ42/Aβ40ratios and larger SDS-stable Aβ oligomers (∼115 kDa). TgCRND8 mice exhibited downregulation of BDNF transcripts III and IV; transcript IV is also downregulated in AD. Furthermore, in all transgenic mouse strains, there was a correlation between levels of large oligomers, Aβ42/Aβ40, and severity of BDNF decrease. These data show that the amount and species of Aβ vary among transgenic mouse models of AD and are negatively correlated with BDNF levels. These findings also suggest that the effect of Aβ on decreased BDNF expression is specific to the aggregation state of Aβ and is dependent on large oligomers.Keywords
This publication has 76 references indexed in Scilit:
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promotersGenomics, 2007
- Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma CellsJournal of Neuroscience, 2007
- Mouse and rat BDNF gene structure and expression revisitedJournal of Neuroscience Research, 2006
- Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of CalciumPublished by Elsevier BV ,2006
- Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 miceNeurobiology of Disease, 2006
- Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse modelNature Medicine, 2006
- Phosphorylation of Amyloid Precursor Protein (APP) at Thr668 Regulates the Nuclear Translocation of the APP Intracellular Domain and Induces NeurodegenerationMolecular and Cellular Biology, 2006
- The Neuropathological Diagnosis of Alzheimer’s Disease: Clinical-Pathological StudiesNeurobiology of Aging, 1997
- Amyloidogenicity of rodent and human βA4 sequencesFEBS Letters, 1993